Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Zobi 2012 Dalton Trans"

From Bioblast
 
Line 6: Line 6:
|journal=Dalton Trans
|journal=Dalton Trans
|abstract=Cyanocobalamin (B<sub>12</sub>)) offers a biocompatible scaffold for CO-releasing 17-electron dicarbonyl complexes based on the cis-trans-[Re<sup>II</sup>(CO)<sub>2</sub>Br<sub>2</sub>]<sup>0</sup> core. A Co-C≡N-Re conjugate is produced in a short time and high yield from the reaction of [Et<sub>4</sub>N]<sub>2</sub>[Re<sup>II</sup>Br<sub>4</sub>(CO)<sub>2</sub>] (ReCORM-1) with B<sub>12</sub>. The B<sub>12</sub>-Re<sup>II</sup>(CO)<sub>2</sub> derivatives show a number of features which make them pharmaceutically acceptable CO-releasing molecules (CORMs). These cobalamin conjugates are characterized by an improved stability in aqueous aerobic media over the metal complex alone, and afford effective therapeutic protection against ischemia-reperfusion injury in cultured cardiomyocytes. The non-toxicity (at μM concentrations) of the resulting metal fragment after CO release is attributed to the oxidation of the metal and formation in solution of the ReO<sub>4</sub><sup>-</sup> anion, which is among the least toxic of all of the rare inorganic compounds. Theoretical and experimental studies aimed at elucidating the aqueous chemistry of ReCORM-1 are also described.
|abstract=Cyanocobalamin (B<sub>12</sub>)) offers a biocompatible scaffold for CO-releasing 17-electron dicarbonyl complexes based on the cis-trans-[Re<sup>II</sup>(CO)<sub>2</sub>Br<sub>2</sub>]<sup>0</sup> core. A Co-C≡N-Re conjugate is produced in a short time and high yield from the reaction of [Et<sub>4</sub>N]<sub>2</sub>[Re<sup>II</sup>Br<sub>4</sub>(CO)<sub>2</sub>] (ReCORM-1) with B<sub>12</sub>. The B<sub>12</sub>-Re<sup>II</sup>(CO)<sub>2</sub> derivatives show a number of features which make them pharmaceutically acceptable CO-releasing molecules (CORMs). These cobalamin conjugates are characterized by an improved stability in aqueous aerobic media over the metal complex alone, and afford effective therapeutic protection against ischemia-reperfusion injury in cultured cardiomyocytes. The non-toxicity (at μM concentrations) of the resulting metal fragment after CO release is attributed to the oxidation of the metal and formation in solution of the ReO<sub>4</sub><sup>-</sup> anion, which is among the least toxic of all of the rare inorganic compounds. Theoretical and experimental studies aimed at elucidating the aqueous chemistry of ReCORM-1 are also described.
|mipnetlab=CH Zurich Gassmann M, CH Zurich Lundby C
|mipnetlab=CH Zurich Gassmann M, CH Zurich Lundby C, US CO Colorado Springs Jacobs RA
}}
}}
{{Labeling
{{Labeling
|area=Respiration, mt-Medicine, Pharmacology;toxicology
|area=Respiration, mt-Medicine, Pharmacology;toxicology
|injuries=Ischemia-reperfusion
|organism=Rat
|organism=Rat
|tissues=Heart
|tissues=Heart
|preparations=Permeabilized cells
|preparations=Permeabilized cells
|injuries=Ischemia-reperfusion
|couplingstates=ROUTINE
|couplingstates=ROUTINE
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|additional=2016-10
|additional=2016-10
}}
}}

Latest revision as of 12:06, 28 March 2018

Publications in the MiPMap
Zobi F, Blacque O, Jacobs RA, Schaub MC, Bogdanova AY (2012) 17 e- rhenium dicarbonyl CO-releasing molecules on a cobalamin scaffold for biological application. Dalton Trans 41:370-8.

» PMID: 21881676

Zobi F, Blacque O, Jacobs RA, Schaub MC, Bogdanova AY (2012) Dalton Trans

Abstract: Cyanocobalamin (B12)) offers a biocompatible scaffold for CO-releasing 17-electron dicarbonyl complexes based on the cis-trans-[ReII(CO)2Br2]0 core. A Co-C≡N-Re conjugate is produced in a short time and high yield from the reaction of [Et4N]2[ReIIBr4(CO)2] (ReCORM-1) with B12. The B12-ReII(CO)2 derivatives show a number of features which make them pharmaceutically acceptable CO-releasing molecules (CORMs). These cobalamin conjugates are characterized by an improved stability in aqueous aerobic media over the metal complex alone, and afford effective therapeutic protection against ischemia-reperfusion injury in cultured cardiomyocytes. The non-toxicity (at μM concentrations) of the resulting metal fragment after CO release is attributed to the oxidation of the metal and formation in solution of the ReO4- anion, which is among the least toxic of all of the rare inorganic compounds. Theoretical and experimental studies aimed at elucidating the aqueous chemistry of ReCORM-1 are also described.


O2k-Network Lab: CH Zurich Gassmann M, CH Zurich Lundby C, US CO Colorado Springs Jacobs RA


Labels: MiParea: Respiration, mt-Medicine, Pharmacology;toxicology 

Stress:Ischemia-reperfusion  Organism: Rat  Tissue;cell: Heart  Preparation: Permeabilized cells 


Coupling state: ROUTINE 

HRR: Oxygraph-2k 

2016-10